2019
$221M
from 7 investors over 7 rounds
Orna Therapeutics raised $221M on August 16, 2022
Investors: Merck Group and MPM Capital
Orna Therapeutics raised $80M on February 24, 2021
Investors: Astellas Venture Capital L.L.C., MPM Capital, Bristol-Myers Squibb, UK and -
Orna Therapeutics raised $20M on January 1, 2020
Investors: MPM Capital